Getinge AB (publ) (STO:GETI.B)
Sweden · Delayed Price · Currency is SEK 230.30
+1.20 (0.52%)
Jul 24, 2026, 5:29 PM CET
Getinge AB Financials Overview
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 34,236 | 34,969 | 34,759 | 31,827 | 28,292 | 27,049 |
Revenue Growth | -3.56% | 0.60% | 9.21% | 12.50% | 4.59% | -9.29% |
Gross Profit Gross Profit Growth | 16,640 | 16,654 | 16,153 | 14,495 | 13,410 | 13,580 |
Operating Income Operating Income Growth | 4,314 | 3,789 | 2,854 | 3,736 | 3,626 | 4,371 |
Net Income Net Income Growth | 2,676 | 2,258 | 1,638 | 2,412 | 2,491 | 2,970 |
Earnings Per Share EPS Growth | 9.83 | 8.29 | 6.01 | 8.86 | 9.15 | 10.90 |
EPS Growth | 79.71% | 37.94% | -32.17% | -3.17% | -16.05% | -8.33% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Acute Care Therapies Acute Care Therapies Growth | 17,983 | 18,675 | 17,948 | 16,529 | 15,285 | 15,527 |
Life Science Life Science Growth | 4,529 | 4,498 | 4,552 | 4,325 | 4,026 | 3,558 |
Surgical Workflows Surgical Workflows Growth | 11,722 | 11,796 | 12,258 | 10,974 | 8,981 | 7,965 |
Revenue (Total) Revenue (Total) Growth | 34,236 | 34,969 | 34,759 | 31,827 | 28,292 | 27,049 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,052 | 3,423 | 2,964 | 2,764 | 5,747 | 4,078 |
Total Debt Total Debt Growth | 11,100 | 10,884 | 10,727 | 8,076 | 5,824 | 4,306 |
Net Cash (Debt) Net Cash Growth | -9,048 | -7,461 | -7,763 | -5,312 | -77 | -228 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -33.22 | -27.39 | -28.50 | -19.50 | -0.28 | -0.84 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 5,035 | 3,949 | 4,577 | 2,957 | 3,367 | 6,560 |
Capital Expenditures CapEx Growth | -297 | -1,314 | -1,309 | -1,353 | -1,136 | -930 |
Free Cash Flow Free Cash Flow Growth | 4,738 | 2,635 | 3,268 | 1,604 | 2,231 | 5,630 |
Free Cash Flow Growth | 27.88% | -19.37% | 103.74% | -28.10% | -60.37% | -8.52% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 48.60% | 47.63% | 46.47% | 45.54% | 47.40% | 50.21% |
Operating Margin | 12.60% | 10.84% | 8.21% | 11.74% | 12.82% | 16.16% |
Pretax Margin | 10.87% | 8.99% | 6.57% | 10.50% | 12.27% | 15.48% |
Profit Margin | 7.85% | 6.51% | 4.76% | 7.63% | 8.89% | 11.09% |
FCF Margin | 13.84% | 7.54% | 9.40% | 5.04% | 7.89% | 20.81% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 4.750 | 4.750 | 4.600 | 4.400 | 4.250 | 4.000 |
Dividend Per Share Growth | 3.26% | 3.26% | 4.54% | 3.53% | 6.25% | 33.33% |
Dividend Yield | 2.06% | 2.13% | 2.48% | 1.93% | 1.89% | 0.80% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 23.44 | 26.39 | 30.21 | 25.32 | 23.64 | 36.25 |
Forward PE | 19.19 | 19.96 | 18.26 | 21.68 | 20.80 | 34.95 |
P/FCF Ratio | 16.48 | 22.62 | 15.13 | 38.09 | 26.41 | 19.11 |
PS Ratio | 1.83 | 1.70 | 1.42 | 1.92 | 2.08 | 3.98 |